As Duane Boise, CEO of MMJ International Holdings, recently remarked:"Patients deserve treatments backed by science, not guesswork. If cannabinoid therapies are going to become part of modern medicine ...

Methods developed and validated to establish the “World Bank of NK Cells” from healthy donors and cancer patientsSingle ...

TV18, the fourth edition draws more than 250 nominations from 90+ global companiesBOSTON--(BUSINESS WIRE)--$LTTS #AI--The ...

YolTech Therapeutics, a late clinical-stage biotechnology company developing in vivo gene-editing therapies, today announced that the U.S. Food and Drug Administration (FDA) has approved the ...

At four months, people using Libre technology had a 0.6% greater reduction in HbA1c and 2.5 more hours a day in the healthy range vs. those using finger pricking1,2Improvements were participant-led, ...

D Bioprinting Market OutlookThe global 3D bioprinting market is poised to witness robust growth at a CAGR of 12–15% over the ...

Japanese Data Center Marks Company’s Continued Commitment to Meeting the Needs of Local Customers and Furthering Regional Market LeadershipTOKYO--(BUSINESS WIRE)--New Relic, the Intelligent ...

WILMINGTON, DE / ACCESS Newswire / March 13, 2026 / Electric Metals (USA) Limited (TSXV:EML)(OTCQB:EMUSF) (the "Company") a U.S.-based critical minerals and advanced materials company, today announced ...

AV Laboratories, a biotechnology-driven skincare brand focused on clinical longevity, today announced the appointment of Dr.

KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and ...

Aptar Pharma, a global leader in drug delivery, dosing, protection technologies and services, today announced a technical collaboration with COVIRIX Medical Pty Ltd (“COVIRIX Medical”), an Australian ...

Expanded Charitable Funding will Support Phase 1 Multiple Ascending Dose Trial and Long-Term Toxicology Studies for TIX100, a Novel Oral Therapy Targeting Beta Cell Health in Type 1 DiabetesBIRMINGHAM ...